Paty BW - Search Results

1

Effects of GLP-1-(7-36)NH2, GLP-1-(7-37), and GLP-1- (9-36)NH2 on intravenous glucose tolerance and glucose-induced insulin secretion in healthy humans.

Vahl TP, Paty BW, Fuller BD, Prigeon RL, D'Alessio DA. Vahl TP, et al. Among authors: paty bw. J Clin Endocrinol Metab. 2003 Apr;88(4):1772-9. doi: 10.1210/jc.2002-021479. J Clin Endocrinol Metab. 2003. PMID: 12679472

2

Suppression of glucose production by GLP-1 independent of islet hormones: a novel extrapancreatic effect.

Prigeon RL, Quddusi S, Paty B, D'Alessio DA. Prigeon RL, et al. Am J Physiol Endocrinol Metab. 2003 Oct;285(4):E701-7. doi: 10.1152/ajpendo.00024.2003. Epub 2003 May 28. Am J Physiol Endocrinol Metab. 2003. PMID: 12773303 Free article. Clinical Trial.

3

Comparison of the [13C]glucose breath test to the hyperinsulinemic-euglycemic clamp when determining insulin resistance.

Lewanczuk RZ, Paty BW, Toth EL. Lewanczuk RZ, et al. Among authors: paty bw. Diabetes Care. 2004 Feb;27(2):441-7. doi: 10.2337/diacare.27.2.441. Diabetes Care. 2004. PMID: 14747226

4

Managing myocardial infarction in the diabetic patient.

Paty BW. Paty BW. Endocrinol Metab Clin North Am. 2000 Dec;29(4):831-42. doi: 10.1016/s0889-8529(05)70167-5. Endocrinol Metab Clin North Am. 2000. PMID: 11149165 Review.

5

2022 Canadian Cardiovascular Society Guideline for Use of GLP-1 Receptor Agonists and SGLT2 Inhibitors for Cardiorenal Risk Reduction in Adults.

Mancini GBJ, O'Meara E, Zieroth S, Bernier M, Cheng AYY, Cherney DZI, Connelly KA, Ezekowitz J, Goldenberg RM, Leiter LA, Nesrallah G, Paty BW, Piché ME, Senior P, Sharma A, Verma S, Woo V, Darras P, Grégoire J, Lonn E, Stone JA, Yale JF, Yeung C, Zimmerman D. Mancini GBJ, et al. Among authors: paty bw. Can J Cardiol. 2022 Aug;38(8):1153-1167. doi: 10.1016/j.cjca.2022.04.029. Can J Cardiol. 2022. PMID: 35961754

6

Beta-score: an assessment of beta-cell function after islet transplantation.

Ryan EA, Paty BW, Senior PA, Lakey JR, Bigam D, Shapiro AM. Ryan EA, et al. Among authors: paty bw. Diabetes Care. 2005 Feb;28(2):343-7. doi: 10.2337/diacare.28.2.343. Diabetes Care. 2005. PMID: 15677790

7

Intrahepatic islet transplantation in type 1 diabetic patients does not restore hypoglycemic hormonal counterregulation or symptom recognition after insulin independence.

Paty BW, Ryan EA, Shapiro AM, Lakey JR, Robertson RP. Paty BW, et al. Diabetes. 2002 Dec;51(12):3428-34. doi: 10.2337/diabetes.51.12.3428. Diabetes. 2002. PMID: 12453896

8

Assessment of the severity of hypoglycemia and glycemic lability in type 1 diabetic subjects undergoing islet transplantation.

Ryan EA, Shandro T, Green K, Paty BW, Senior PA, Bigam D, Shapiro AM, Vantyghem MC. Ryan EA, et al. Among authors: paty bw. Diabetes. 2004 Apr;53(4):955-62. doi: 10.2337/diabetes.53.4.955. Diabetes. 2004. PMID: 15047610

9

Five-year follow-up after clinical islet transplantation.

Ryan EA, Paty BW, Senior PA, Bigam D, Alfadhli E, Kneteman NM, Lakey JR, Shapiro AM. Ryan EA, et al. Among authors: paty bw. Diabetes. 2005 Jul;54(7):2060-9. doi: 10.2337/diabetes.54.7.2060. Diabetes. 2005. PMID: 15983207

10

Assessment of glycemic control after islet transplantation using the continuous glucose monitor in insulin-independent versus insulin-requiring type 1 diabetes subjects.

Paty BW, Senior PA, Lakey JR, Shapiro AM, Ryan EA. Paty BW, et al. Diabetes Technol Ther. 2006 Apr;8(2):165-73. doi: 10.1089/dia.2006.8.165. Diabetes Technol Ther. 2006. PMID: 16734547

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

53 results

Search Page